Difference between revisions of "Flexible tissues"
(Created page with "In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relat...") |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relationship results from the dose-dependent loss of proliferating functional cells through their mitotic death, together with the feedback-mediated stimulation of compensatory proliferation, leading to an even enhanced cell loss by doomed divisions. | In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relationship results from the dose-dependent loss of proliferating functional cells through their mitotic death, together with the feedback-mediated stimulation of compensatory proliferation, leading to an even enhanced cell loss by doomed divisions. | ||
| − | + | '''Return to [[ICRP Glossary|Glossary]]''' | |
| − | ''[[ICRP Glossary]] | ||
Latest revision as of 14:24, 7 September 2021
In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relationship results from the dose-dependent loss of proliferating functional cells through their mitotic death, together with the feedback-mediated stimulation of compensatory proliferation, leading to an even enhanced cell loss by doomed divisions.
Return to Glossary